ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

IPSC Century Therapeutics Inc

2,88
-0,27 (-8,57%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Century Therapeutics Inc IPSC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,27 -8,57% 2,88 23:25:51
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,22 2,82 3,25 2,88 3,15
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/4/202413:00GLOBECentury Therapeutics to Present at Chardan’s 8th Annual..
11/4/202413:00GLOBECentury Therapeutics Strengthens Position in Autoimmune..
08/4/202422:05GLOBECentury Therapeutics Presents New Preclinical Data..
25/3/202412:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
19/3/202412:00GLOBECentury Therapeutics to Present at the H.C. Wainwright 2nd..
14/3/202412:30GLOBECentury Therapeutics Reports Full Year 2023 Financial..
09/3/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:40EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:19EDGAR2Form 144 - Report of proposed sale of securities
06/3/202400:03GLOBECentury Therapeutics Announces Six Upcoming Poster..
21/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202419:04EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
16/2/202422:18EDGAR2Form 144 - Report of proposed sale of securities
07/2/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:25EDGAR2Form 144 - Report of proposed sale of securities
05/2/202421:23EDGAR2Form 144 - Report of proposed sale of securities
01/2/202413:00GLOBECentury Therapeutics to Present at the Guggenheim Healthcare..
19/1/202423:03EDGAR2Form 8-K - Current report
11/12/202316:30EDGAR2Form 8-K - Current report
09/12/202318:00GLOBECentury Therapeutics Presents Initial Data from CNTY-101..
06/12/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/12/202313:46EDGAR2Form 8-K - Current report
06/12/202313:30GLOBECentury Therapeutics Receives FDA Clearance of IND..
21/11/202313:00GLOBECentury Therapeutics to Present at the Piper Sandler 35th..
09/11/202313:56EDGAR2Form 8-K - Current report
09/11/202313:01GLOBECentury Therapeutics Reports Third Quarter 2023 Financial..
09/11/202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:00GLOBECentury Therapeutics and FUJIFILM Cellular Dynamics Announce..
03/11/202321:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202314:00GLOBECentury Therapeutics to Present Initial Clinical Data..
03/10/202314:00EDGAR2Form 8-K - Current report
26/9/202313:00GLOBECentury Therapeutics to Present at the Chardan 7th Annual..
09/8/202313:40EDGAR2Form 8-K - Current report
09/8/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202313:30GLOBECentury Therapeutics Reports Second Quarter 2023 Financial..
29/6/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202322:05EDGAR2Form 8-K - Current report
11/5/202313:30GLOBECentury Therapeutics Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

Delayed Upgrade Clock